Found 92 matching trials
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer NA This study aims to evaluate the clinical feasibility of first-line immunoch...
Show More Location
The Obstetrics and Gynecology Hospital of Fudan University
Learn More & Join Trial
A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer PHASE2 This is a multicenter, open-label, phase II clinical study conducted in Chi...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC PHASE3 This randomized, Phase III, multicenter, open-label study designed to evalu...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer PHASE2 To compare outcomes between the CRS group and the control group in patients...
Show More Location
National Cancer Center, Korea
Learn More & Join Trial
A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer PHASE3 This is a randomized, double-blind, placebo-controlled phase III study to e...
Show More Location
Fudan University Shanghai Cancer Hospital
Learn More & Join Trial
A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors PHASE1 This is an open-label, multicenter, Phase Ib dose-escalation study to asses...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer PHASE3 This is A Randomized, Double-blind, Placebo-controlled Phase III Study to E...
Show More Status
Active Not Recruiting
Location
Women's Hospital School Of Medicine Zhejiang University
Learn More & Join Trial
Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer PHASE2 The purpose of this study is to test whether it is safe to treat your cance...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer PHASE2 This is a single-arm, multicenter, phase II study to investigate efficacy a...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer PHASE2 This study is a single-arm, multicenter, Phase II study to evaluate the eff...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial